{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T13:43:16Z","timestamp":1795095796611,"version":"4.10.2"},"reference-count":47,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>CD8+ T cell-numbers rapidly expand and then contract after exposure to their cognate antigen. Here we show that the sustained frequencies of transgene product-specific CD8+ T cells elicited by replication-defective adenovirus vectors are linked to persistence of low levels of transcriptionally active adenovirus vector genomes at the site of inoculation, in liver, and lymphatic tissues. Continuously produced small amounts of antigen maintain fully active effector CD8+ T cells, while also allowing for their differentiation into central memory cells. The long-term persistence of adenoviral vectors may be highly advantageous for their use as vaccines against pathogens for which T-cell\u2013mediated protection requires both fully activated T cells for immediate control of virus-infected cells and central memory CD8+ T cells that, because of their higher proliferative capacity, may be suited best to eliminate cells infected by pathogens that escaped the initial wave of effector T cells.<\/jats:p>","DOI":"10.1182\/blood-2007-02-062117","type":"journal-article","created":{"date-parts":[[2007,5,18]],"date-time":"2007-05-18T17:12:54Z","timestamp":1179508374000},"page":"1916-1923","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":197,"title":["Adenoviral vectors persist in vivo and maintain activated CD8+ T cells: implications for their use as vaccines"],"prefix":"10.1182","volume":"110","author":[{"given":"Nia","family":"Tatsis","sequence":"first","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie C.","family":"Fitzgerald","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"},{"name":"Children's Hospital of Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Reyes-Sandoval","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"},{"name":"Oxford University, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly C.","family":"Harris-McCoy","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Hensley","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongming","family":"Zhou","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Wen","family":"Lin","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang","family":"Bian","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi Quan","family":"Xiang","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"Iparraguirre","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Lopez-Camacho","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"},{"name":"Posgrado en Ciencias Quimicas, Instituto de Quimica\u2013, Instituto de Ciencias de la Universidad de Puebla (ICUAP), Benem\u00e9rita Universidad Aut\u00f3noma de Puebla (BUAP), Puebla, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. John","family":"Wherry","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hildegund C. J.","family":"Ertl","sequence":"additional","affiliation":[{"name":"Wistar Institute, Philadelphia, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111714233888200_B1","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.0505126102","article-title":"Antibody vs. HIV in a clash of evolutionary titans.","volume":"102","author":"Burton","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111714233888200_B2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev.immunol.24.021605.090605","article-title":"HIV vaccines.","volume":"24","author":"McMichael","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"2019111714233888200_B3","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1126\/science.309.5737.1003","article-title":"HIV\/AIDS. Hedged bet: an unusual AIDS vaccine trial.","volume":"309","author":"Cohen","year":"2005","journal-title":"Science"},{"key":"2019111714233888200_B4","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1097\/00002030-200100005-00018","article-title":"The HIV vaccine pipeline, from preclinical to phase III.","volume":"15","author":"Schultz","year":"2001","journal-title":"AIDS"},{"key":"2019111714233888200_B5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1146\/annurev.med.55.091902.104344","article-title":"Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors.","volume":"55","author":"Shiver","year":"2004","journal-title":"Annu Rev Med"},{"key":"2019111714233888200_B6","doi-asserted-by":"crossref","first-page":"11491","DOI":"10.1073\/pnas.191380898","article-title":"Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.","volume":"98","author":"Bru\u00f1a-Romero","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111714233888200_B7","doi-asserted-by":"crossref","first-page":"8286","DOI":"10.1128\/JVI.74.18.8286-8291.2000","article-title":"Direct ex vivo kinetic and phenotypic analyses of CD8 + T-cell responses induced by DNA immunization.","volume":"74","author":"Hassett","year":"2000","journal-title":"J Virol"},{"key":"2019111714233888200_B8","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.1128\/JVI.76.21.10608-10616.2002","article-title":"Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes.","volume":"76","author":"Garnett","year":"2002","journal-title":"J Virol"},{"key":"2019111714233888200_B9","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1128\/JCM.41.10.4636-4641.2003","article-title":"Multiplexed, real-time PCR for quantitative detection of human adenovirus.","volume":"41","author":"Gu","year":"2003","journal-title":"J Clin Microbiol"},{"key":"2019111714233888200_B10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/sj.gt.3302675","article-title":"Chimpanzee-origin adenovirus vectors as vaccine carriers.","volume":"13","author":"Tatsis","year":"2006","journal-title":"Gene Ther"},{"key":"2019111714233888200_B11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.4049\/jimmunol.170.3.1416","article-title":"A simian replication-defective adenoviral recombinant vaccine to HIV-1 gag.","volume":"170","author":"Fitzgerald","year":"2003","journal-title":"J Immunol"},{"key":"2019111714233888200_B12","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4049\/jimmunol.177.2.831","article-title":"Stimulation history dictates memory CD8 T-cell phenotype: implications for prime-boost vaccination.","volume":"177","author":"Masopust","year":"2006","journal-title":"J Immunol"},{"key":"2019111714233888200_B13","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ymthe.2006.03.027","article-title":"A Chimpanzee-Origin Adenovirus Vector Expressing the Rabies Virus Glycoprotein as an Oral Vaccine against Inhalation Infection with Rabies Virus.","volume":"14","author":"Zhou","year":"2006","journal-title":"Mol Ther"},{"key":"2019111714233888200_B14","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/415335a","article-title":"Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.","volume":"415","author":"Barouch","year":"2002","journal-title":"Nature"},{"key":"2019111714233888200_B15","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1089\/10430340252939032","article-title":"Constitutive expression of the adenovirus E3\u201314.7K protein does not prolong adenovirus vector DNA persistence but protects mice against lipopoly-saccharide-induced acute hepatitis.","volume":"13","author":"Gantzer","year":"2002","journal-title":"Hum Gene Ther"},{"key":"2019111714233888200_B16","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1084\/jem.172.6.1653","article-title":"E3\/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins.","volume":"172","author":"Jefferies","year":"1990","journal-title":"J Exp Med"},{"key":"2019111714233888200_B17","doi-asserted-by":"crossref","first-page":"9716","DOI":"10.1128\/JVI.76.19.9716-9723.2002","article-title":"The adenovirus E3 RID complex protects some cultured human T and B lymphocytes from Fas-induced apoptosis.","volume":"76","author":"McNees","year":"2002","journal-title":"J Virol"},{"key":"2019111714233888200_B18","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2741\/1604","article-title":"Functions of the adenovirus E4 proteins and their impact on viral vectors.","volume":"10","author":"Weitzman","year":"2005","journal-title":"Front Biosci"},{"key":"2019111714233888200_B19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ymthe.2003.11.008","article-title":"CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.","volume":"9","author":"Reyes-Sandoval","year":"2004","journal-title":"Mol Ther"},{"key":"2019111714233888200_B20","first-page":"51","article-title":"The role of neutralizing antibodies in HIV infection.","volume":"8","author":"Humbert","year":"2006","journal-title":"AIDS Rev"},{"key":"2019111714233888200_B21","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1128\/JVI.78.8.3930-3940.2004","article-title":"Highly effective control of an AIDS virus challenge in macaques by using vesicular stomatitis virus and modified vaccinia virus Ankara vaccine vectors in a single-boost protocol.","volume":"78","author":"Ramsburg","year":"2004","journal-title":"J Virol"},{"key":"2019111714233888200_B22","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/JVI.79.8.4580-4588.2005","article-title":"Vaccine-elicited memory cytotoxic T lymphocytes contribute to Mamu-A*01-associated control of simian\/human immunodeficiency virus 89.6P replication in rhesus monkeys.","volume":"79","author":"Seaman","year":"2005","journal-title":"J Virol"},{"key":"2019111714233888200_B23","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T-cell depletion in simian immunodeficiency virus-infected macaques.","volume":"189","author":"Jin","year":"1999","journal-title":"J Exp Med"},{"key":"2019111714233888200_B24","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"2019111714233888200_B25","doi-asserted-by":"crossref","first-page":"4650","DOI":"10.1128\/JVI.68.7.4650-4655.1994","article-title":"Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome.","volume":"68","author":"Koup","year":"1994","journal-title":"J Virol"},{"key":"2019111714233888200_B26","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells.","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"2019111714233888200_B27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.20052237","article-title":"Secondary memory CD8+ T-cells are more protective but slower to acquire a central-memory phenotype.","volume":"203","author":"Jabbari","year":"2006","journal-title":"J Exp Med"},{"key":"2019111714233888200_B28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.immunol.24.021605.090727","article-title":"Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis.","volume":"24","author":"Ma","year":"2006","journal-title":"Annu Rev Immunol"},{"key":"2019111714233888200_B29","first-page":"83","article-title":"Specificity and plasticity of memory lymphocyte migration.","volume":"308","author":"Rodrigo Mora","year":"2006","journal-title":"Curr Top Microbiol Immunol"},{"key":"2019111714233888200_B30","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","article-title":"Central memory and effector memory T-cell subsets: function, generation, and maintenance.","volume":"22","author":"Sallusto","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"2019111714233888200_B31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2006.05.001","article-title":"Immunopathogenesis of acute AIDS virus infection.","volume":"18","author":"Picker","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"2019111714233888200_B32","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20040876","article-title":"Lineage relationships, homeostasis, and recall capacities of central- and effector-memory CD8 T-cells in vivo.","volume":"201","author":"Bouneaud","year":"2005","journal-title":"J Exp Med"},{"key":"2019111714233888200_B33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.0105-2896.2006.00402.x","article-title":"Protective \u2018immunity\u2019 by pre-existent neutralizing antibody titers and preactivated T-cells but not by so-called \u2018immunological memory\u2019.","volume":"211","author":"Zinkernagel","year":"2006","journal-title":"Immunol Rev"},{"key":"2019111714233888200_B34","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.4049\/jimmunol.163.10.5535","article-title":"Naive, effector, and memory CD8 T-cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial.","volume":"163","author":"Cerwenka","year":"1999","journal-title":"J Immunol"},{"key":"2019111714233888200_B35","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/eji.200635874","article-title":"Unidirectional development of CD8+ central memory T-cells into protective Listeria-specific effector memory T-cells.","volume":"36","author":"Huster","year":"2006","journal-title":"Eur J Immunol"},{"key":"2019111714233888200_B36","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni889","article-title":"Lineage relationship and protective immunity of memory CD8 T-cell subsets.","volume":"4","author":"Wherry","year":"2003","journal-title":"Nat Immunol"},{"key":"2019111714233888200_B37","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.4049\/jimmunol.175.6.3502","article-title":"Vaccine-induced CD8+ central memory T-cells in protection from simian AIDS.","volume":"175","author":"Vaccari","year":"2005","journal-title":"J Immunol"},{"key":"2019111714233888200_B38","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene.","volume":"77","author":"Casimiro","year":"2003","journal-title":"J Virol"},{"key":"2019111714233888200_B39","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1128\/JVI.79.10.6516-6522.2005","article-title":"Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates.","volume":"79","author":"Santra","year":"2005","journal-title":"J Virol"},{"key":"2019111714233888200_B40","doi-asserted-by":"crossref","first-page":"7392","DOI":"10.1128\/JVI.78.14.7392-7399.2004","article-title":"Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes.","volume":"78","author":"Reyes-Sandoval","year":"2004","journal-title":"J Virol"},{"key":"2019111714233888200_B41","doi-asserted-by":"crossref","first-page":"6594","DOI":"10.1128\/JVI.02497-06","article-title":"Effect of pre-existing immunity to antigens of adenovirus of the human serotype 5 on immune responses of nonhuman primates to vaccine regimens based on human or chimpanzee-derived adenovirus vectors.","volume":"81","author":"McCoy","year":"2007","journal-title":"J Virol"},{"key":"2019111714233888200_B42","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1086\/510248","article-title":"IL-7R alpha versus CCR7 and CD45 as markers of virus-specific CD8 + T-cell differentiation: contrasting pictures in blood and tonsillar lymphoid tissue.","volume":"195","author":"Sauce","year":"2007","journal-title":"J Infect Dis"},{"key":"2019111714233888200_B43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2004-11-4469","article-title":"Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8 + T-cells during persistent infection.","volume":"106","author":"Dunne","year":"2005","journal-title":"Blood"},{"key":"2019111714233888200_B44","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF01317433","article-title":"The nature of adenovirus persistence in human adenoid vegetations.","volume":"48","author":"Snejdarov\u00e1","year":"1975","journal-title":"Arch Virol"},{"key":"2019111714233888200_B45","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/1074-7613(94)90074-4","article-title":"MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.","volume":"1","author":"Yang","year":"1994","journal-title":"Immunity"},{"key":"2019111714233888200_B46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1286-4579(03)00015-7","article-title":"Turnover of memory-phenotype CD8 + T-cells.","volume":"5","author":"Sprent","year":"2003","journal-title":"Microbes Infect"},{"key":"2019111714233888200_B47","doi-asserted-by":"crossref","first-page":"7689","DOI":"10.1128\/JVI.77.13.7689-7695.2003","article-title":"Episomal persistence of recombinant adenoviral vector genomes during the cell cycle in vivo.","volume":"77","author":"Ehrhardt","year":"2003","journal-title":"J Virol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/6\/1916\/1481853\/zh801807001916.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/6\/1916\/1481853\/zh801807001916.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T22:20:58Z","timestamp":1683843658000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/110\/6\/1916\/24190\/Adenoviral-vectors-persist-in-vivo-and-maintain"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,15]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,9,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-02-062117","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,15]]}}}